Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

Objectives To evaluate the potential of immunosuppressed patients to mount B-cell and T-cell responses to COVID-19 booster vaccination (third vaccination).Methods Patients with primary immunodeficiency (PID), immune-mediated inflammatory diseases (IMIDs) on CD20-depleting treatment with rituximab (R...

Full description

Bibliographic Details
Main Authors: Frank Behrens, Harald Burkhardt, Michaela Koehm, Sandra Ciesek, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Gerd Geisslinger, Holger F Rabenau
Format: Article
Language:English
Published: BMJ Publishing Group 2023-09-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003094.full

Internet

https://rmdopen.bmj.com/content/9/3/e003094.full

Similar Items